Syringe Exchange An Intervention that Works to Control the Spread of Hepatitis C and HIV. Health Department

Similar documents
Syringe Exchange Programs: Getting Started

SYRINGE SERVICES PROGRAMS IN INDIANA

High Impact Prevention for People Who Inject Drugs. June 30, 2015

Targeted Outreach & Other Strategies for Increasing HCV Testing

Jefferson County Syringe Exchange Program (SEP) Annual Report 2017

Harm Reduction and Syringe Exchange Programs in the City and County of Los Angeles

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

QuADS Organisational Standards and Professional Competencies in needle exchange

Overview of Evidence for Sterile Syringe Access. Hilary McQuie Western Director Harm Reduction Coalition

Prevention Point Philadelphia

Alabama s Emerging Hepatitis C Epidemic and Vulnerability to an Outbreak of HIV Infection Among Persons Who Inject Drugs

who use drugs in order to assist them in reducing harm while in the cycle of addiction

The LENOWISCO Health District (LHD) is located in the heart of the beautiful Appalachian mountains of southwest Virginia, extending east from the

1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0

Poland nationalupdate

Hepatitis B Virus and the Opioid Crisis

Questions & Answers. What are the risks associated with consumption drug use?

Hospitalizations for Infective Endocarditis Among Individuals Using Opioids in Philadelphia,

Slide 1. Slide 2. Slide 3. What is injection safety Safe injection practices- Blood glucose monitoring Sharp safety.

Needle Exchange Programs

Amanda Archer, BS, MPH

Substance Abuse. Among current drinkers, men in nonmetro areas consume 5 or more drinks in one day than those in metro areas (56% vs.

Local Legislative Approval and Program Certification

HIV Testing. ECHO Hep C. Judith Feinberg, MD June 22, 2017

Syringe Exchange Programs December 2005

Becoming a harm reduction distribution agency in Toronto - information session

Patient Care Planning Group April 3, 2014

Training Objectives. By the end of this session you will be able to: 2. Recognize key principles of harm reduction.

Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

MOBILE OUTREACH. A guide to help plan and implement a Mobile Outreach Vehicle (MOV)-based risk reduction intervention program.

Harm Reduction. West Virginia Rural Health Conference, October 17, 2018

HIV Transmission and Injection Drug Use: Lessons From the Indiana Outbreak. Diane M. Janowicz

HIV & HCV in TN: State of the State

Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary

Pharmacy Needle and Syringe Programme. Enhanced Contract

Building a New Approach to Health Care Services for Hard to Reach Clients

Syringe Service Programs: Platforms for Engagement. September 28, 2018 Melissa Green, MASW, LSW Harm Reduction Program Manager Columbus Public Health

Summary Report: Survey of Hepatitis C Virus counseling and testing services at HIV counseling and testing sites, and health service sites.

Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018

MAKE SMART INJECTION CHOICES INJECTION PROVIDERS GUIDE FOR SAFE INJECTIONS

Syringe Access & Disposal Services in SF

Protecting and Promoting Health and Equity

Tajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan

Harm Reduction at Lummi Tribal Health Center. Jessica Rienstra RN

Albuquerque Health Care for the Homeless (AHCH)

What s The Point? The unique role of pharmacists in HIV/HCV. prevention efforts BAY AREA AND NORTH COAST AREA APRIL 30, 2016

Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

CitiWide Harm Reduction

Historical Perspectives

Hepatitis A in Boston BPHC Board Meeting October 17, 2018

Syringe Exchange Program Plan

NDEWS Sentinel Community Site Advance Report 2016: Selected Findings for Heroin, Fentanyl, and Methamphetamine

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

The Opioid Epidemic in Alabama

COMMUNITY CONSULTATION SERIES Women Who Have Sex With Women (WSW) and HIV Prevention

Overview of Syringe Exchange Programs. New York City Police Academy November 24, 2004

Integrating Hepatitis Services into HIV Programs: The Local Health Department Perspective

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,

Frequently Asked Questions about HIV/AIDS: Transmission and Prevention How is HIV passed from one person to another?

DHMH Activities toward Implementing Requirements of Md. Code Ann., Health-General , Hepatitis C Prevention and Control within Maryland

Signs of success latest national NESI data?

5/2/2016. Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Learning Objectives

Hepatitis C in Massachusetts Epidemiology and Public Health Response

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin

REPORT ON EXPLORATORY SITE VISITS FOR COMPREHENSIVE USER ENGAGEMENT SITE (CUES)

Ethics of Over the Counter Syringe Sales To Injection Drug Users. Stephanie J. Andrews December 2006

Healthcare-Related Outbreaks of Hepatitis B and C in the United States

Narrative Science-based literature on Syringe Exchange Programs (SEPs)

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

IDU Outreach Project. Program Guidelines

Supervised Consumption Facilities Review of the Evidence SHARON LARSON, PHD NORMA PADRON, PHD JENNIFER MASON TYLER BOGACZYK

Infectious and Communicable Diseases Prevention and Control Program Annual Service Plan A. Community Need and Priorities We are situated rurally with

PH52. Audit tool for the implementation of. NICE public health guidance 52 Needle and syringe programmes

PREVENTION OF HCV IN PEOPLE WHO INJECT DRUGS

Hepatitis C COLVILLE FOCUSED DIAGNOSIS, MANAGEMENT, TREATMENT

WA DRUG ABUSE STRATEGY OFFICE

Hawai i to Zero. Timothy McCormick Harm Reduction Services Branch Hawai i Department of Health. January 16, 2018

Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative

Public Health Response to HCV in Oregon: Need for Screening and Treatment. Ann Thomas, MD, MPH Acute and Communicable Disease Prevention

Syringe Exchange/Harm Reduction Program Mid-Year Report

Innovative Ways to Fund Harm Reduction Services New Mexico

Injecting infections What you need to know

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.

HIV, drugs and the legal environment

Dear Friend of SAY, Together, we are making a difference. Matt Martin, Executive Director

NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA

Taking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre

PREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES

SAN FRANCISCO SAFE INJECTION SERVICES TASK FORCE

Productivity & Yield analysis

April 10, Audio Access Dial-in: Participant Access Code: #

Hepatitis C Strategy

Marguerite A. Erme, DO, MPH Summit County Public Health November

UNDERSTANDING SYRINGE EXCHANGE IN UTAH. Amelia Prebish, MPH Heather Bush, BS Mindy Vincent, LCSW

Hepatitis C Best Practice Guidelines For Local Health Departments

Transcription:

Syringe Exchange An Intervention that Works to Control the Spread of Hepatitis C and HIV Wayne Crabtree Administrator, Louisville Metro Department of Public Health and Wellness According to the CDC Kentucky has the nation's highest rate of acute hepatitis C with a rate of 5.1 cases in 2013 and 4.0 in 2014 per every 100,000 people compared to the national rate of 0.7. Cases of acute hepatitis C increased by 240% between 2009 and 2013 More than 56,000 Kentuckians may have chronic hepatitis C infection, according to the Cabinet for Health and Family Services. According to the CDC the primary cause of hepatitis C is sharing needles among people who inject drugs (PWID). A recent CDC study found that hepatitis C cases across four Appalachian states -- Kentucky, Tennessee, West Virginia, and Virginia -- more than tripled between 2006 and 2012. The study is the first from the CDC to link the rise in hepatitis C to an increase in injection drug use. 1

A syringe exchange is an evidence-based intervention to prevent the spread of hepatitis C, HIV and other blood borne diseases. Hepatitis C among PWIDs dropped nearly 40% in New York city after widespread implementation of syringe exchanges. A 2005 study found that HIV rates decreased by nearly 6% in cities that had syringe exchange programs compared to a national increase of nearly 6% per year. Definition A syringe exchange is: A public health intervention for people who inject drugs It provides new, sterile syringes and HIV prevention supplies. It also provides a means to dispose of used and potentially contaminated syringes Syringe exchanges have been proven to reduce the spread of HIV, hepatitis C and other blood-borne infections An evidence-based practice to connect people who inject drugs to: Counseling and treatment Testing for hepatitis C, HIV, and other infections Education about the harms associated with drug use and how to minimize them Safe disposal of contaminated equipment 2

There are syringe exchange programs in about 230 cities across America. Syringe exchange programs can lead people who inject drugs to seek testing, counseling and treatment. Syringe exchange programs bring PWID in contact with the health system where they can be tested for hepatitis C and HIV and, if positive, be treated. Syringe exchange programs can make drug treatment options known to addicted individuals. Studies show that program participants are five times more likely to enter drug treatment than those who do participate in syringe exchange programs. Syringe exchange programs do not lead to increased drug use in the cities that implement them. Many scientific studies, including a Surgeon General s report, show that syringe exchanges do not increase drug use when conducted with referrals to both drug treatment and hepatitis C and HIV testing, medical care and support services. 3

Syringe exchange programs reduce the number of contaminated needles in the streets and parks. Syringe exchange and disposal programs actually encourage individuals to bring back used syringes to trade them in at the syringe exchange site. A study published in the American Journal of Public Health showed that San Francisco s syringe exchange program reduced the risk from infectious syringes left by injection drug users. The study was based on a survey of more than 600 injection drug users and a visual inspection of 1,000 city blocks in areas heavily trafficked by drug users. Why Did Louisville Establish Its Syringe Exchange Program? Austin Indiana just 35 miles from Louisville had 181 new HIV cases as a result of needle sharing among people who inject drugs. About 86% of those infected with HIV in Austin also have hepatitis C. 4

In a city the size of Louisville that would proportionately mean more than 27,100 new hepatitis C and 31,600 new HIV cases. In a state the size of Kentucky that would proportionately mean 158,000 new hepatitis C cases and almost 184,000 new HIV cases. To prevent the spread of hepatitis C and HIV and to link people to the health system where they can get drug treatment, the Metro Council and the Board of Health approved the Louisville Metro Syringe Exchange Program We opened June 10, 2015. And so far it s working! 5

Program Goals 1. To prevent the spread of blood-borne diseases spread by needle sharing such as hepatitis C and HIV. 2. To link people who inject drugs to the health system where they can get treatment. The Louisville Metro Syringe Exchange provides: Free sterile syringes Sharps containers to safely return used syringes Hepatitis C testing Referral to Hepatitis C treatment HIV testing and prevention supplies Referral to HIV treatment Referrals for addiction treatment Education and counseling on STD prevention, wound treatment and syringe disposal Naloxone on-site and referrals for the take home use of naloxone A Certified Alcohol and Drug Counselor (CADC) provides staffing for the site in addition to a Health Educator. The Seven Counties Services, Inc., Jefferson Alcohol and Drug Abuse Center (JADAC) has assigned a full time addictions treatment case manager: Works with participants on drug treatment options Makes treatment referrals 6

We have contracted with Volunteers of America, Mid-States to provide community outreach. This month our main syringe site will move from an RV parked outside our Gray Street headquarters in downtown Louisville to refurbished space inside the building. This site is open six days a week. We have also opened two community sites that are each open one day a week. Participants in the Louisville Metro Syringe Exchange Program have come from every Zip Code in Jefferson County as well as from surrounding Zip Codes in Indiana and Kentucky 7

In fact, participants have come from throughout central Kentucky as well as from far eastern and far western Kentucky. We use the Needs Based Exchange Model. More and more syringes are being returned each week as participants come to trust the program. The ratio of sterile syringes distributed to used syringes returned has narrowed each week from a high of 8.3 to 1 in June, 2015 to 1.7 to 1 in June 2016. Returning clients are bringing back 74% of their syringes. The program is working! Through June 4, 2016 the Louisville Metro Syringe Exchange Program has: Had 3,603 participants with 1691(47%) returning participants. Tested 312 people for hepatitis C. Tested 138 people-hepatitis C preliminary + in LMSEP. Referred 202 people for hepatitis C treatment. Tested 371 people for HIV. Tested 2 people for HIV that were preliminary + in LMSEP. Referred 10 people for HIV treatment. Referred 215 people for drug treatment. Prevented the same sort of outbreak of hepatitis C and HIV that occurred in Austin Indiana. 8

Questions? Contact Info Wayne Crabtree Administrator Louisville Metro Department of Public Health and Wellness Email: Wayne.Crabtree@louisvilleky.gov Office: 502-574-8328 9